The general condition of the GXZY-NAFL, GXZY-NASH, and GXZY-fibrosis mice at each pathological stage improved, compared with that of the MG-NAFL, MG-NASH, and MG-fibrosis mice, and the AST, ALT, and liver TG indicators also decreased. The gene discussed is GPT; the disease is myasthenia gravis.